'Active treatment arm' diaporamas de présentation

Improving FDA/Industry Interactions: Suggestions from FDA/CDER Statisticians

Improving FDA/Industry Interactions: Suggestions from FDA/CDER Statisticians. Rafia Bhore, Ph.D. Janice Derr, Ph.D. FDA / CDER / Office of Biostatistics. The views expressed in this presentation are those of the speakers and not necessarily of the U.S. Food and Drug Administration (FDA).

657 views • 22 slides